| |
|
|
| |
|
|
| |
| |
hum-molgen: events in
bioscience and medicine |
|
| |
September, 21 2026 |
your calendar for events in genetics, biotechnology
and medicine |
|
| |
|
|
|
|
|
|
| |
advertisement |
|
search meetings |
|
recent postings |
|
|
|
|
| |
=> advertise at hum-molgen
|
|
|
|
| - |
As pet parents increasingly seek proactive solutions to support their pets' quality of life and longevity, brands are under pressure to deliver effective, clinically substantiated pet health products : Formulate Pet Health Products to Improve Aging, Mobility and Immunity |
| - |
Lyophilization has become an important development and commercialization strategy for modern parenteral products, including biologics, antibody-drug conjugates, mRNA-lipid nanoparticles, viral vectors: Lyophilization by Design: Improve Stability and Accelerate Scale-Up (Broadcast 2) |
| - |
Lyophilization has become an important development and commercialization strategy for modern parenteral products, including biologics, antibody-drug conjugates, mRNA-lipid nanoparticles, viral vectors: Lyophilization by Design: Improve Stability and Accelerate Scale-Up (Broadcast 1) |
| - |
Clinical trials succeed or fail at the intersection of two communities: patients who volunteer their time and participation and sites that dedicate resources, expertise and empathy to guide them throu: Build Patient-Site Trust to Improve Clinical Trial Retention |
| - |
Life sciences organizations have more data than ever, yet many of the sources used to guide Commercial and Medical Affairs' strategy reveal market change weeks or months after it occurs. This webinar : Detect Clinician Activity Shifts Earlier to Improve Market Readiness |
| - |
Medical information teams face a critical inflection point as they move toward first product approval, launch or rapid commercial growth. A PDUFA date or the release of new clinical data can quickly e: The Last Human Mile in Medical Information: Scaling Biotech Launch Support |
| - |
Biopharmaceutical teams are increasingly looking to AI to improve process development and optimization. However, the biggest constraint is often not the model; it’s the data. If experiments are run at: High-Throughput Antibody Workflows for AI-Enabled Process Optimization |
| - |
With peptide conjugate therapies achieving blockbuster sales and around 300 peptide-drug conjugates having entered clinical development, interest is expanding across new conjugate types and therapeuti: Accelerate Peptide Synthesis Timelines for Complex Conjugates |
| - |
The future of cell and gene therapy will be shaped not only by clinical breakthroughs but also by the industry's ability to connect patients, providers, payers and support services in an increasingly : Scale Cell & Gene Therapy Access for Stronger Launch Readiness (Broadcast 1) |
| - |
The future of cell and gene therapy will be shaped not only by clinical breakthroughs but also by the industry's ability to connect patients, providers, payers and support services in an increasingly : Scale Cell & Gene Therapy Access for Stronger Launch Readiness (Broadcast 2) |
 Get the latest news as RSS feed
|
|
| |
|
|
|
|
|
|
| |
news alert (free) |
|
write an announcement |
|
other resources |
|
| |
|
|
|
|
|
|
| |
To receive our regular news
alert (free - including summary of recent position postings) please register at our
bulletin board.
|
|
Please use our webform for direct postings after you have been set up your account.
By using this site you reach more than
8.000 news alert subscribers and 150.000 HUM-MOLGEN web users and
several mirror sites (e.g. Calender
of Events) in the US, China, Israel and France.
To further improve "hum-molgen: events in bioscience and
medicine" we have redesigned our database and web submission
form. The updated version enables the set up of accounts. By this
way advertisers are in the position to change postings and to submit
multiple postings more efficient. Please report potential problems
/ suggestions for further improvements to the www administrator Kai Garlipp (kai+www@garlipp.de).
|
|
HGMIS Calendar
of Genetic Meetings and Training
Calendar
LifeSciencesInfo.com
How to
Attend a Meeting by Dave Barry
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
WWW: Kai Garlipp,
Frank S.
Zollmann.
7.0 © 1995-2026 HUM-MOLGEN. All rights reserved.
Liability, Copyright and Imprint. |
|